RPL34P36

Across TCGA pan-cancer cohorts, RPL34P36 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RPL34P36 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RPL34P36 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL34P36 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

THCA, BLCA, and ACC are the cancer types where RPL34P36 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	III,IV	0.548	0.963	<.001	111	view →
BLCA	DFS	Tertile	III,IV	0.231	0.580	.001	60	view →
ACC	OS	Tertile	All	0.193	0.820	<.001	57	view →
KIRC	DFS	Tertile	All	0.239	0.640	.009	54	view →
HNSC	OS	Tertile	All	0.910	0.649	.016	54	view →
PAAD	OS	Tertile	All	0.100	0.590	<.001	36	view →
UCEC	OS	Tertile	All	0.680	0.877	.011	30	view →
LUSC	OS	Tertile	All	0.319	0.733	.004	18	view →
BRCA	OS	Tertile	III,IV	0.200	0.555	.028	9	view →
MESO	DFS	Tertile	III,IV	0.078	0.376	.012	9	view →
ESCA	DFS	Tertile	II,III,IV	0.612	0.280	.039	6	view →
LGG	DFS	Tertile	All	0.595	0.847	.018	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RPL34P36–THCA (OS)

Open the THCA breakdown →